Orasure’s Covid-19 Saliva Test Gets Emergency Use Authorization

OraSure Technologies’ ORAcollect RNA saliva collection device has been included in the FDA Emergency Use Authorization granted to Quadrant Biosciences for a Covid-19 laboratory test.

• This is the sixth EUA to include a collection device from the Company’s DNA Genotek subsidiary and the first to exclusively utilize a saliva collection method
• The non-invasive saliva swab test determines the presence or absence of SARS-CoV-2 viral RNA, and will be immediately available for use by clinical laboratories, physicians’ offices, urgent care clinics and hospitals
• NOTE: Aug. 6, OraSure’s Covid-19 Test Setback to Disappoint, Jefferies Says

To view the source of this ...